BAFNA PHARMACEUTICALS LTD
BAFNAPH.NS
₹ 80.00
1%

Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Ltd is a Small Cap stock that belongs to the Pharmaceuticals & Drugs sector. The current live share price of Bafna Pharma is ₹ 80.00 that is ₹ 0.67 0.84% with respect to the previous day’s close price. The stock price of Bafna Pharma was last updated 1 day ago.

Bafna Pharma Stock Price Performance

In the below section, we have evaluated the stock’s price performance for the last traded day as well as historical time frames.

Bafna Pharma Live Share Price Analysis

BAFNA PHARMACEUTICALS LTD
₹ 80.00
Open ₹ 81.80
High ₹ 81.80
Marketcap 1.89B
Close ₹ 80.00
Low ₹ 80.00
Volume ₹ 471.00

The stock of Bafna Pharmaceuticals Ltd strated the trade at an Open price of ₹ 81.80 when the trading at exchange began for the day. It touched an Intraday High price of ₹ 81.80 and an Intraday Low price of ₹ 80.00%. As per last updated 1 day ago, the Shares of Bafna Pharma were trading at a price of ₹ 80.00 which is ₹ 0.67 0.84% as compared the price ₹ 79.33 at which the stock close on the previous trading day. The total traded volume for the day stood at 471 number of shares.

Candlestick Chart of Bafna Pharma Share Price Movements

The following candlestick Chart of the Stock shows how the Open, High, Low, Close (OHLC) Price of the share has performed in the last month (30-day period).

Historical Performance of Bafna Pharma Shares

52 Week RangePrice52 Weeks Low52 Weeks High
₹ 80.00₹ 73.25₹ 113.00

Here is Bafna Pharma’s price performance analysis over the last year. The stock has seen the 52 weeks high price level of ₹ 113.00. On the lower side, the stock has been to the 52 weeks low price level of ₹ 73.25. It’s last traded price was ₹ 80.00 as on last update 1 day ago. The one-year line chart clearly shows how the price of Bafna Pharma’s stock has moved in the last twelve months.

The Company has posted an earnings of ₹ 0.18 per share (EPS TTM) in the trailing twelve months period. Bafna Pharma’s last annual dividend rate was %, which translates to a % of annual dividend yield.

Line Chart of Bafna Pharma Stock Price

Here is the chart of stock price performance for the last one year. You can also view the price performance of a different period by selecting the time frame from the top right corner.

Companies Similar to Bafna Pharma

Bafna Pharmaceuticals Ltd belongs to the Pharmaceuticals & Drugs sector. It has several competitors in the same industry. The snapshot of the live share price of some of the companies similar to Bafna Pharma are listed below. You can click and view the details of stock analysis, current and historical share price, company background information about each company.

Share Price Snapshot Companies Similar to Bafna Pharma

Select list of companies is given below. To view more about the Industry and see other companies from Industry, click on the industry name.
ABBOTINDIA.NSABBOTT INDIA LIMITED
₹ 27,718.50
NSE
₹ 603.80
2.23%
ALBERTDAVD.NSALBERT DAVID LIMITED
₹ 1,268.95
NSE
₹ 5.80
0.45%
ALCHEM.NSALCHEM.NS,0P0000B9XC,0
₹ 3.15
NSE
₹ 0.0000
0.00%
ALEMBICLTD.NSALEMBIC LIMITED
₹ 124.11
NSE
₹ 0.85
0.69%

About Bafna Pharma

Bafna Pharmaceuticals Ltd is a Private Company. The company operates in the Pharmaceuticals & Drugs sector. It is a pharmaceutical company. Incorporated in 1995, it has around 26 years of operations. Bafna Pharma live share price is ₹ 80.00. It is a Small Cap stock and had a market capitalization of ₹ 1,892,504,064.00 as on 1 day ago.

  • Bafna Pharma is engaged in the manufacture of drugs and medicines.
  • The Company operates through generic pharmaceutical segment.
  • The Company caters to both domestic and international markets.
  • Its HAEMATINIC products include Raricap, Raricap Forte, Raricap L Suspension, Raricap Combi, Raricap Drops, Raricap M, Raricap Maa and Raricap S Injection. Raricap is indicated for iron deficiency anemia. Raricap Forte is indicated for iron deficiency anemia in pregnancy and lactation. Raricap L Suspension is indicated for iron deficiency anemia in children. Raricap Combi is indicated for iron deficiency anemia and calcium deficiency during pregnancy and lactation. Raricap Drops is indicated for iron deficiency and iron deficiency anemia in infants and toddlers.
  • Its other products include LoPIH, BSF, Drofenac, I-Gest-200, Molev Syrup, AFENAC-P, AFENAC TH, NOCAF Syrup, IZABOF 250 milligram (MG), IZABOF 500 MG and IZABOF Suspension.

The registered office of Bafna Pharma is located in Chennai, Tamil Nadu. The registrar and share transfer agent for Bafna Pharma is Cameo Corporate Services Ltd. The Stock Exchanges on which shares of Bafna Pharmaceuticals Ltd is listed includes BSE, NSE, MCX.

BAFNA PHARMACEUTICALS LTD
Status: Active
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 363
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, and internationally. The company was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited operates as a subsidiary of SRJR Lifesciences LLP.
AddressBafna Towers, Chennai, India
CountryIndia
Phone91 44 2526 7517
Websitehttps://www.bafnapharma.com

Bafna Pharma Recent News

No Recent News found for Bafna Pharmaceuticals Ltd.
Exit mobile version